feed,title,long_url,short_url
Benzinga,Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge,https://benzinga.com/news/earnings/24/05/38651590/dow-surges-over-100-points-eyepoint-pharmaceuticals-shares-plunge,https://da.gd/0etW2
Benzinga,$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today,https://benzinga.com/insights/news/24/05/38651526/100-invested-in-this-stock-10-years-ago-would-be-worth-300-today,https://da.gd/l2uUN6
Benzinga,$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today,https://benzinga.com/insights/news/24/05/38651523/100-invested-in-this-stock-5-years-ago-would-be-worth-400-today,https://da.gd/gxLjv
Benzinga,"Thanks To Apple, This Analyst Is Optimistic On ARM, Microchip Technology And More Ahead Of Earnings",https://benzinga.com/analyst-ratings/analyst-color/24/05/38651469/thanks-to-apple-this-analyst-is-optimistic-on-arm-microchip-technology-and-more-ahe,https://da.gd/B8HYC
Benzinga,BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance,https://benzinga.com/general/biotech/24/05/38651467/biocryst-pharmaceuticals-fantastic-q1-earnings-rides-on-outstanding-orladeyo-performance,https://da.gd/CKoqzh
